Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Abbott GmbH & Co., KG et al v. Centocor Ortho Biotech, Inc.
Case Number:
4:09-cv-11340
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 11, 2013
J&J's Win Upheld In Antibody Patent Fight Against Abbott
A Massachusetts federal judge on Friday upheld a jury's verdict that found two antibody patents held by Abbott GmbH & Co. KG were invalid, finalizing a courtroom win for Johnson & Johnson subsidiary Janssen Biotech Inc.
-
September 25, 2012
Jury Finds For J&J Unit In Row Over Abbott Antibody Patents
A Massachusetts federal jury on Tuesday handed down a verdict in favor of a Johnson & Johnson unit sued by Abbott GmbH & Co. KG over a psoriasis treatment Abbott said infringed its antibody patents, finding claims in both patents invalid.
-
March 12, 2012
J&J Unit's Stelara Infringes Abbott Patents, Judge Rules
A Massachusetts federal judge ruled Friday on several competing summary judgment bids in a legal battle between Abbott GmbH & Co. KG and Johnson & Johnson unit Janssen Biotech Inc., finding that Janssen's psoriasis treatment Stelara infringes two human antibody patents.